does glp-1 cause cancer Glucagon-like peptide-1 medicines and Glucagon-like peptide 1 receptor agonists
Description
[DOI] [PubMed] [Google Scholar] 56.Payne S, et al
Over the past decade, studies have shown GLP-1 receptor agonists like semaglutide (Ozempic or Wegovy) reduce food seeking, but also alcohol intake, cocaine reward, nicotine self-administration, and relapse-like behavior spanning multiple drug classes
This can lead to prolonged nausea, bloating, and discomfort
Among folks with overweight or obesity, GLP-1s increase the risk for GERD by about twofold
When blood glucose rises, insulin release increases
What can patients taking weight loss medications expect
